Thirty-nine weeks ended | | October 27, 2012 | | October 29, 2011 | |
| | | | | |
Cash flows from operating activities: | | | | | |
Net earnings | | $ | 27,351 | | $ | 33,322 | |
Adjustments to reconcile net earnings to net cash provided by continuing operations: | | | | | |
Net loss (income) from discontinued operations | | 122 | | (3 | ) |
Depreciation and amortization | | 59,129 | | 59,779 | |
Amortization of deferred gain from asset sales | | (9,453 | ) | (9,451 | ) |
Stock compensation expense | | 622 | | 2,539 | |
Deferred income taxes | | 14,521 | | 8,021 | |
Net loss (gain) from disposition of assets | | 232 | | (61 | ) |
Loss from asset impairment | | 8,802 | | 389 | |
Other | | 88 | | — | |
Changes in assets and liabilities, net of the effects of acquisitions: | | | | | |
Decrease in accounts receivable, prepaid expenses and other | | 26,213 | | 27,767 | |
Increase in merchandise inventories | | (20,116 | ) | (34,874 | ) |
Increase in accounts payable | | 14,510 | | 19,758 | |
Decrease in accrued expenses | | (4,208 | ) | (18,693 | ) |
Decrease in other long-term liabilities | | (1,369 | ) | (3,483 | ) |
Net cash provided by continuing operations | | 116,444 | | 85,010 | |
Net cash (used in) provided by discontinued operations | | (215 | ) | 40 | |
Net cash provided by operating activities | | 116,229 | | 85,050 | |
| | | | | |
Cash flows from investing activities: | | | | | |
Capital expenditures | | (36,760 | ) | (50,793 | ) |
Proceeds from dispositions of assets | | 15 | | 89 | |
Premiums paid on life insurance policies | | — | | (837 | ) |
Acquisitions, net of cash acquired | | — | | (42,901 | ) |
Collateral investment | | — | | (4,763 | ) |
Net cash used in investing activities | | (36,745 | ) | (99,205 | ) |
| | | | | |
Cash flows from financing activities: | | | | | |
Borrowings under line of credit agreements | | 1,780 | | 5,181 | |
Payments under line of credit agreements | | (1,780 | ) | (5,181 | ) |
Borrowings on trade payable program liability | | 123,408 | | 97,400 | |
Payments on trade payable program liability | | (82,904 | ) | (85,367 | ) |
Payment for finance issuance cost | | (6,442 | ) | (2,441 | ) |
Borrowings under new debt | | 200,000 | | — | |
Debt payments | | (295,122 | ) | (809 | ) |
Dividends paid | | — | | (4,757 | ) |
Proceeds from stock issuance | | 1,999 | | 605 | |
Net cash (used in) provided by financing activities | | (59,061 | ) | 4,631 | |
Net increase (decrease) in cash and cash equivalents | | 20,423 | | (9,524 | ) |
Cash and cash equivalents at beginning of period | | 58,244 | | 90,240 | |
Cash and cash equivalents at end of period | | $ | 78,667 | | $ | 80,716 | |
| | | | | |
Supplemental cash flow information: | | | | | |
Cash paid for income taxes | | $ | 2,635 | | $ | 1,015 | |
Cash paid for interest | | $ | 28,554 | | $ | 14,577 | |
Accrued purchases of property and equipment | | $ | 2,008 | | $ | 1,486 | |